MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-16-2026
Applied Genetic Technologies Corporation Current Ratio 2011-2026 | AGTC
Annual Current Ratio Applied Genetic Technologies Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.79 | 3.08 | 3.42 | 6.83 | 6.13 | 4.54 | 2.53 | 19.4 | 30.5 | 7.14 | 0.0828 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 30.5 | 0.0828 | 7.77 |
Quarterly Current Ratio Applied Genetic Technologies Corporation
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.44 | - | 2.17 | 2.26 | 2.7 | 2.26 | 3.97 | 2.36 | 2.91 | 2.36 | 5.18 | 3.7 | 5.08 | 3.7 | 8 | 3.36 | 3.06 | 3.36 | 6.05 | 6.65 | 5.9 | 6.65 | 3.93 | 3.46 | 2.94 | 3.46 | 2.27 | 2.08 | 1.86 | 2.08 | 25.5 | 37 | 32.5 | 37 | 10.7 | 30.6 | 30.6 | - | 7.14 | 7.14 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 37 | 1.44 | 8.51 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
1.84 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
5.42 | - | 1.35 % | $ 17.8 M |  China |
 |
Coherus BioSciences
CHRS
|
1.31 | $ 1.59 | -3.64 % | $ 186 M |  USA |
 |
AgeX Therapeutics
AGE
|
0.995 | - | -10.17 % | $ 12.2 K | USA |
 |
I-Mab
IMAB
|
8.96 | - | - | $ 866 M | China |
 |
Celldex Therapeutics
CLDX
|
10.4 | $ 31.43 | -0.85 % | $ 2.09 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
0.922 | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M | France |
 |
BioNTech SE
BNTX
|
7.95 | $ 95.95 | 2.69 % | $ 23.2 B | Germany |
 |
AstraZeneca PLC
AZN
|
1.75 | - | - | $ 96.9 B |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
1.43 | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
0.796 | - | 0.74 % | $ 768 M |  Israel |
 |
Compugen Ltd.
CGEN
|
7.46 | $ 2.63 | -5.4 % | $ 246 M | Israel |
 |
Abcam plc
ABCM
|
3.2 | - | - | $ 4.9 B | Britain |
 |
Galera Therapeutics
GRTX
|
11.2 | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
2.68 | - | -18.52 % | $ 27.3 M | Britain |
 |
Affimed N.V.
AFMD
|
1.69 | - | -34.95 % | $ 21.5 M | Germany |
 |
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
8.41 | - | - | $ 231 M | USA |
 |
Celyad Oncology SA
CYAD
|
1.88 | - | - | $ 12.5 M |  Belgium |
 |
Berkeley Lights
BLI
|
2.69 | - | -7.31 % | $ 87 M | USA |
 |
Generation Bio Co.
GBIO
|
1.59 | - | - | $ 344 M | USA |
 |
IMV
IMV
|
0.826 | - | - | $ 13.1 M | Canada |
 |
Akero Therapeutics
AKRO
|
10.9 | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
6.18 | - | 0.23 % | $ 488 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
6.17 | - | - | $ 7.46 M | Israel |
 |
Cyclacel Pharmaceuticals
CYCCP
|
6.09 | - | -4.36 % | $ 27 M | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
2.53 | - | - | $ 384 M | Britain |
 |
Gracell Biotechnologies
GRCL
|
5.9 | - | - | $ 3.37 B | China |
 |
Anika Therapeutics
ANIK
|
14.4 | $ 14.53 | -2.48 % | $ 208 M | USA |
 |
Advaxis
ADXS
|
3.37 | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
1.22 | - | 5.93 % | $ 314 M | Canada |
 |
CRISPR Therapeutics AG
CRSP
|
6.6 | $ 56.18 | -0.35 % | $ 5.05 B |  Schweiz |
 |
Aeglea BioTherapeutics
AGLE
|
12.4 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
2.47 | - | - | $ 867 M | Germany |
 |
AIkido Pharma
AIKI
|
2.59 | - | 1.93 % | $ 17.4 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.76 | $ 3.35 | -0.3 % | $ 5.51 M | Israel |
 |
Aptose Biosciences
APTO
|
0.269 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
2.35 | - | -39.0 % | $ 4.57 M | USA |
 |
Albireo Pharma
ALBO
|
2.39 | - | -0.23 % | $ 916 M | USA |
 |
AlloVir
ALVR
|
2.84 | - | 4.14 % | $ 49.1 M | USA |
 |
Allakos
ALLK
|
5.43 | - | - | $ 28.6 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
1.78 | $ 21.46 | 0.09 % | $ 2.73 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
2.19 | - | 3.16 % | $ 1.9 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
2.41 | - | -11.43 % | $ 502 K | USA |
|
Applied Molecular Transport
AMTI
|
2.31 | - | - | $ 10.1 M | USA |